J. Velianou

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
James Velianou, J. Velianou, James L Velianou, J. L. Velianou, J L Velianou, James Louis Velianou, James L. Velianou
Publication record
114 papers · 5,079 citations · H-index 29

PAPERS

Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden: A Randomized Trial.
20254 citationsauthor #8
OCT-based diagnosis, management, and predictors of recurrent stent failure: a cohort study
20251 citationsauthor #17
Use of Intravascular Imaging to Guide Percutaneous Coronary Interventions: A Single-Center Experience from a High-Volume Canadian Centre
20251 citationsauthor #6
Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis From the FAUST and UNIVERSAL Trials
20245 citationsauthor #13
Ultrasound-Guided Femoral Access in Patients With Vascular Closure Devices: Insights From the Randomized UNIVERSAL Trial
20230 citationsauthor #11
CRT-100.01 Ultrasound-Guided Femoral Access in Patients With Vascular Closure Devices: Insights From the Randomized UNIVERSAL Trial
20230 citationsauthor #11
Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
202313 citationsauthor #17
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial.
202311 citationsauthor #11
Bicuspid valve CT registry of balloon‐expandable TAVR: BETTER TAVR registry
20231 citationsauthor #11
TCT-296 Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis of the FAUST and UNIVERSAL Trials
20230 citationsauthor #13
JUMPSTART-TAVR PILOT: EVALUATION OF AN EARLY MOBILIZATION VIRTUAL EXERCISE MODULE POST TAVR
20220 citationsauthor #10
Bespoke valve sizing avoids annular rupture in patients treated with a balloon‐expandable transcatheter heart valve
20223 citationsauthor #9
Design and Rationale of Routine UltrasouNd GuIdance for Vascular AccEss foR Cardiac Procedures: A Randomized TriaL (UNIVERSAL)
20224 citationsauthor #12
Economics of Minimalist Transcatheter Aortic Valve Replacement: Results From the 3M-TAVR Economic Study
202222 citationsauthor #14
605 Validation Of Aortic Valve Computed Tomography Calcium Quantification In Contrast Computed Tomography
20220 citationsauthor #7
Remote ECG monitoring to reduce complications following transcatheter aortic valve implantations: the Redirect TAVI study.
20220 citationsauthor #6
Routine Ultrasonography Guidance for Femoral Vascular Access for Cardiac Procedures: The UNIVERSAL Randomized Clinical Trial.
202258 citationsauthor #12
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.
202238 citationsauthor #12
A Computed Tomography Protocol to Evaluate Coronary Artery Disease prior to Transcatheter Aortic Valve Replacement.
20216 citationsauthor #3
Complete Revascularization in Patients Undergoing a Pharmacoinvasive Strategy for ST-Segment–Elevation Myocardial Infarction
20213 citationsauthor #12
COMPLETE REVASCULARIZATION IN PATIENTS UNDERGOING A PHARMACOINVASIVE STRATEGY FOR STEMI
20210 citationsauthor #12
TCT-343 A Computed Tomography Protocol to Evaluate Coronary Artery Disease Prior to Transcatheter Aortic Valve Replacement
20210 citationsauthor #3
REMOTE ECG MONITORING TO REDUCE COMPLICATIONS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATIONS - THE REDIRECT TAVI STUDY
20215 citationsauthor #4
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease.
202028 citationsauthor #12
Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease
202029 citationsauthor #14
Very early changes in quality of life after transcatheter aortic valve replacement: Results from the 3M TAVR trial.
202024 citationsauthor #10
Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology
202060 citationsauthor #18
Remote Ambulatory Cardiac Monitoring Before and After Transcatheter Aortic Valve Replacement
202014 citationsauthor #4
FEASIBILITY AND EFFECT OF REMOTE AMBULATORY HEART RHYTHM MONITORING PRE AND POST TAVI
20190 citationsauthor #4
Abstract 17178: Variability in Pacemaker Implantation in the 3M TAVR Study: Indications, Outcomes and Implications
20190 citationsauthor #18
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.
2019221 citationsauthor #31
Polygenic Contribution in Individuals With Early-Onset Coronary Artery Disease
201851 citationsauthor #4
Avoiding S3 Valve Over-Sizing by Deployment Balloon Over-Filling: Impact on Rates of Permanent Pacemaker and Other Procedural Complications During TAVR.
20189 citationsauthor #8
TCT-225 Impact of frailty on a minimalist approach and early discharge following TAVR: insights from the 3M TAVR Study
20181 citationsauthor #17
The Presence of a CTO in a Non-Infarct-Related Artery During a STEMI Treated With Contemporary Primary PCI Is Associated With Increased Rates of Early and Late Cardiovascular Morbidity and Mortality: The CTO-TOTAL Substudy.
201829 citationsauthor #12
IMPACT OF LEVEL OF ANAESTHESIA USING THE VANCOUVER CLINICAL PATHWAY FOR TRANSCATHETER AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE 3M TAVR STUDY
20181 citationsauthor #15
TCT-124 Impact of level of anaesthesia using the Vancouver Clinical Pathway for transcatheter aortic valve replacement: Insights from the 3M TAVR Study
20180 citationsauthor #15
Thrombus Aspiration in Patients With High Thrombus Burden in the TOTAL Trial.
201896 citationsauthor #15
Morphological Patterns of€In-Stent Chronic Total€Occlusions
20180 citationsauthor #9
Adult Congenital Heart Disease Intervention: The Canadian Landscape.
20178 citationsauthor #5
MitraClip and Transcatheter Aortic Valve Replacement in a Patient With Recurrent Heart Failure.
20173 citationsauthor #6
Structural Heart Disease Intervention: The Canadian Landscape.
20177 citationsauthor #18
Double Trouble: A Case of Valvular Disease in Pregnancy.
201611 citationsauthor #6
Interpreting angina: symptoms along a gender continuum
20168 citationsauthor #4
SUCCESSFUL VALVE-IN-VALVE TAVI IN PREGNANCY FOR SEVERE DEGENERATIVE BIOPROSTHETIC AORTIC VALVE STENOSIS
20162 citationsauthor #5
Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial.
2016195 citationsauthor #30
Percutaneous Left Atrial Appendage Closure for Thromboembolic Prevention in Atrial Fibrillation
20161 citationsauthor #4
PS189 Safety and Efficacy of Percutaneous Left Atrial Appendage. Single Center-initial Experience
20160 citationsauthor #3
Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patie
201578 citationsauthor #6
Reperfusion Times for Radial Versus Femoral Access in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Observations From the Cardiac Care Network Provincial Primary PCI Registry
201511 citationsauthor #8
Randomized Controlled Trial of Radiation Protection With a Patient Lead Shield and a Novel, Nonlead Surgical Cap for Operators Performing Coronary Angiography or Intervention
201549 citationsauthor #10
Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
201544 citationsauthor #3
Providing optimal regional care for ST-segment elevation myocardial infarction: a prospective cohort study of patients in the Hamilton Niagara Haldimand Brant Local Health Integration Network.
201514 citationsauthor #9
Radial Versus Femoral Access for Coronary Angiography/Intervention in Women With Acute Coronary Syndromes: Insights From the RIVAL Trial (Radial Vs femorAL access for coronary intervention).
201589 citationsauthor #11
Outcomes Following Transcatheter Aortic Valve Implantation (Tavi) in Ontario (2007-2013)
20150 citationsauthor #8
Traditional cardiovascular risk factors and the presence of obstructive coronary artery disease in men and women.
201426 citationsauthor #7
Transcatheter aortic valve implantation in patients with bicuspid aortic valve: A patient level multi-center analysis.
201492 citationsauthor #19
DUAL VERSUS MONO-ANTIPLATELET THERAPY POST-TRANSCATHETER AORTIC VALVE IMPLANTATION: A META-ANALYSIS OF 30-DAY OUTCOMES
20140 citationsauthor #6
RADIAL VERSUS FEMORAL ACCESS FOR CORONARY ANGIOGRAPHY/INTERVENTION IN WOMEN WITH ACUTE CORONARY SYNDROMES: INSIGHTS FROM THE RIVAL TRIAL
20140 citationsauthor #7
Clinical Research Traditional Cardiovascular Risk Factors and the Presence of Obstructive Coronary Artery Disease in Men and Women
20140 citationsauthor #7
THE SYMPOMATIC TIPPING POINT: FACTORS THAT PROMPT MEN AND WOMEN TO SEEK MEDICAL CARE
20143 citationsauthor #5
VARIABILITY IN THE RATES OF NORMAL DIAGNOSTIC CORONARY CATHETERIZATIONS AND NON-INVASIVE PRE-CATHETERIZATION FUNCTIONAL TESTING AT ADVANCED CARDIAC CENTRES IN ONTARIO
20140 citationsauthor #3
Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients.
2014145 citationsauthor #10
Reconstructing angina: cardiac symptoms are the same in women and men.
201352 citationsauthor #4
Treatment assignment of high-risk symptomatic severe aortic stenosis patients referred for transcatheter AorticValve implantation.
201320 citationsauthor #8
Cardiac symptoms in women and men--reply.
20130 citationsauthor #2
Angiotensin Converting Enzyme Inhibitors/ Angiotensin Receptor Blockers and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization: Captain Trial
20131 citationsauthor #6
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry.
2013578 citationsauthor #24
Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings.
2012172 citationsauthor #5
Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience.
2012310 citationsauthor #9
427 Providing a Platform for Organized Care in ST Elevation Myocardial Infarction: The LHIN-4 SMART-AMI Project in Southern Ontario Experience
20120 citationsauthor #12
ST-elevation myocardial infarction: Is there time for Q waves?
20125 citationsauthor #3
Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion: A Population-Based Study
2012101 citationsauthor #6
331 Distribution of response to clopidogrel therapy using vasodilator stimulated phosphoprotein assay in patients undergoing primary percutaneous coronary intervention for ST segment elevation myocardial infarction
20110 citationsauthor #6
664 Incidence and predictive factors of permanent pacemaker implantation following transcatheter aortic valve implantation with a balloon-expandable valve
20110 citationsauthor #5
Left main thrombus as a complication of thrombectomy during primary percutaneous coronary intervention.
201110 citationsauthor #2
Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure.
2011104 citationsauthor #5
715 Reperfusion times for radial vs. femoral access in patients with ST-elevation myocardial infarction undergoing primary PCI: Observations from the CCN provincial primary PCI registry
20110 citationsauthor #6
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.
20101,048 citationsauthor #9
Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis.
2010190 citationsauthor #5
Transcatheter Aortic Valve Implantation in Patients with Bicuspid Aortic Valve Stenosis
20100 citationsauthor #5
Long-term outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice: a Canadian experience.
20108 citationsauthor #3
Improving the timeliness of care for patients with acute ST-elevation myocardial infarction: implications of "self-transport" versus use of EMS.
20107 citationsauthor #2
Identifying women with severe angiographic coronary disease
201026 citationsauthor #6
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) IN BICUSPID AORTIC STENOSIS
20101 citationsauthor #7
Referrals in acute coronary events for CARdiac catheterization: The RACE CAR trial.
201012 citationsauthor #4
Baseline Characteristics of Patients With Paclitaxel-or Sirolimus-Eluting Stents Before Propensity-Score Matching *
20097 citationsauthor #5
Radiation dose in interventional cardiology procedures: urgent need for monitoring dose and establishing diagnostic reference levels.
200811 citationsauthor #5
Cardiogenic shock following nasal septoplasty: a case report and review of the literature
200830 citationsauthor #4
Therapeutic options for cardiogenic shock
20080 citationsauthor #3
Comparison of one-year clinical outcomes with paclitaxel-eluting stents versus bare metal stents in everyday practice.
20084 citationsauthor #3
Computed tomographic coronary angiographic assessment of high-risk coronary anatomy in patients with suspected coronary artery disease and intermediate pretest probability.
200826 citationsauthor #5
Adjunctive Medical Therapy in Percutaneous Coronary Intervention
20070 citationsauthor #1
The relationship of body mass index to outcomes after percutaneous coronary intervention.
200620 citationsauthor #4
Primary and rescue percutaneous coronary intervention with paclitaxel-eluting stent implantation in ST-elevation myocardial infarction.
200613 citationsauthor #3
A randomized pilot study of dalteparin versus unfractionated heparin during percutaneous coronary interventions.
200620 citationsauthor #2
Randomized, Blinded Trial Comparing Fondaparinux With Unfractionated Heparin in Patients Undergoing Contemporary Percutaneous Coronary Intervention: Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation (ASPIRE) Pilot Trial
2005114 citationsauthor #11
Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions.
20057 citationsauthor #3
Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction--the RADIAL-AMI pilot randomized trial.
2005179 citationsauthor #8
1004-48 Randomized trial of radial versus femoral access for primary and rescue angioplasty
20041 citationsauthor #9

TIMELINE

1999 192 citations

2000 36 citations

2001 169 citations

2002 4 citations

2003 2 citations

2004 78 citations

2005 300 citations

2006 53 citations

2007 0 citations

2008 71 citations

2009 7 citations

2010 1,292 citations

2011 114 citations

2012 588 citations

2013 651 citations

2014 266 citations

2015 285 citations

2016 217 citations

2017 18 citations

2018 187 citations

2019 221 citations

2020 155 citations

2021 14 citations

2022 125 citations

2023 25 citations

2024 5 citations

2025 6 citations

J. Velianou

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT